India is launching ambitious science initiatives. However, current financial rules designed for conventional procurement hinder R&D. A new ...

Moderna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...

Moderna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.

US Health Secretary Robert F. Kennedy Jr. stopped 22 vaccine projects. These projects used mRNA technology. The vaccines aimed to fight COV...

Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine enhances immunity...

Russia has developed an mRNA cancer vaccine and plans to release it publicly in early 2025, free of charge. Pre-clinical trials show it inh...

Decades before Covid vaccines, scientists had been working on messenger ribonucleic acid (mRNA) vaccines targeting cancer.

The Florida Department of Health (Department) conducted an analysis through a self-controlled case series, which is a technique originally ...

The Subject Expert Committee recommended the authorisation in a meeting held on Friday. The vaccine is developed by Pune-based Gennova Biop...

About 70 lakh doses of the vaccine have already been cleared by the government’s nodal Central Drug Laboratory (CDL) at Kasauli and it is e...

The official noted that the vaccine can be stored in normal cold chain conditions and transported, which is a "big thing".

Katalin Kariko and Drew Weissman are being seen as potential winners.

While almost 1 billion people have been fully vaccinated in China, the country is still lacking an mRNA shot, with most of the population i...

The study, published in the journal JAMA Pediatrics, offers the first direct data of vaccine safety during breastfeeding and could allay co...

Both the Pfizer and Moderna vaccines are mRNA vaccines, which contain tiny fragments of the genetic material known as “messenger ribonuclei...

Providence will sell up to 30 million doses of its mRNA vaccine, PTX-COVID19-B, to Biological E., and will also provide the necessary techn...

Currently, the two mRNA vaccines that are under use for Covid-19 are by US drug makers Pfizer and Moderna and have shown to have over 90% e...